-
CUDC-907 Protocol and QC Guide
2026-09-11
CUDC-907 (SKU A4097) is a dual PI3K and HDAC inhibitor for coordinated studies of PI3K/AKT signaling, histone acetylation, cell-cycle behavior, and apoptosis in cancer cell models. It is intended for controlled scientific research workflows only and should not be used for diagnostic, therapeutic, or clinical applications.
-
Berberine, RXRα/PPARγ/NEDD4, and Atherosclerosis
2026-09-11
This 2025 study identifies an RXRα/PPARγ/NEDD4 axis through which berberine suppresses SASP-related inflammation in atherosclerotic foam cells. Its combination of mouse, cellular, transcriptomic, and macrophage-specific knockdown experiments provides a useful framework for testing how nuclear-receptor signaling controls inflammatory aging in plaques.
-
PKH26 Red Fluorescent Cell Linker Kit Guide
2026-09-10
The PKH26 Red Fluorescent Cell Linker Kit (SKU K2410) provides membrane-associated red fluorescence for tracking labeled cells and monitoring signal partitioning during proliferation. It is intended for cell membrane lipid region fluorescent labeling in vitro or in vivo, not for intracellular targets or non-membrane labeling.
-
Arrb2, 6-ketoLCA, and Hepatic Ischemia–Reperfusion Injury
2026-09-10
The reference study identifies hepatocyte β-arrestin 2 (Arrb2) as a regulator of hepatocyte–macrophage communication during hepatic ischemia–reperfusion injury, linking Arrb2 expression to increased 6-ketoLCA and M2 macrophage polarization. Its combination of clinical association, hepatocyte-selective mouse genetics, hypoxia–reoxygenation experiments, and metabolite analysis provides a mechanistic framework for studying immunometabolic control of liver injury.
-
Ionizing Radiation and Altered Neuronal Differentiation
2026-09-09
The reference study shows that ionizing radiation does more than reduce neural stem-cell survival: it drives an altered neuronal differentiation program in C17.2 cells through PI3K-linked STAT3–mGluR1 and p53 signaling. Its combination of morphology, neuronal markers, function-related genes, pathway inhibition, and primary-cell validation provides a useful framework for studying radiation-associated neural dysfunction.
-
Sodium chloride: Buffer and Cell Culture Guide
2026-09-09
Sodium chloride is an inorganic salt used to control ionic strength and osmotic balance in buffer preparation, cell culture media, and related biochemical workflows. This guide covers practical handling and QC boundaries; prepare solutions in water, use them promptly, and do not select DMSO or ethanol as solvents.
-
DOTAP for Immune-Metabolic Assay Design
2026-09-08
1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) enables controlled nucleic acid delivery for transfection and functional genomics. This guide connects its assay-design utility with recent findings on lymph-node-targeted immune metabolism while clearly separating established evidence from testable applications.
-
CDK4/6–BET Synergy in Pancreatic Cancer
2026-09-08
Gu et al. show that combining the CDK4/6 inhibitor palbociclib with the BET inhibitor JQ1 can counteract a pro-invasive response associated with CDK4/6 blockade in pancreatic ductal adenocarcinoma. The study links this effect to coordinated regulation of GSK3β-mediated Wnt/β-catenin signaling and TGF-β/Smad crosstalk, providing a rationale for combination treatment rather than CDK4/6 inhibition alone.
-
Adipose-Neural Axis in Cardiac Arrhythmia
2026-09-07
Fan et al. establish a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY–Y1R pathway. The study connects this signaling axis to NCX and CaMKII activity, arrhythmic cardiomyocyte behavior, and clinical changes in patients with atrial fibrillation, while identifying several experimentally testable intervention points.
-
Ionomycin Calcium Salt: Research Workflows
2026-09-05
Build controlled calcium perturbation assays for secretion, protein regulation, and apoptosis research with Ionomycin calcium salt. This workflow-focused guide also shows how calcium phenotyping can complement, but not replace, DNA-repair profiling in oncology studies.
-
BODIPY 581/591 C11 for Ferroptosis Assays
2026-09-05
BODIPY 581/591 C11 converts membrane oxidation into a measurable red-to-green fluorescence ratio, supporting lipid peroxidation detection in live cells and model membranes. This guide connects practical probe handling with endothelial ferroptosis workflows relevant to diabetic osteoporosis, while emphasizing controls, selectivity, and troubleshooting.
-
Cdk5, AMPK, and Microglial Control of Neuronal Ferroptosis
2026-09-04
This 2025 study identifies a linked Cdk5–AMPK–microglia pathway that contributes to neuronal ferroptosis after ischemic stroke. Pharmacological Cdk5 inhibition and AMPK activation improved neurological outcomes in mice and reduced proinflammatory microglial activity and ferroptosis-related neuronal injury, with additive effects when combined.
-
NSC 87877: A Causal Assay Framework for SHP2
2026-09-04
NSC 87877 is a potent Shp2 inhibitor that can reveal how catalytic phosphatase activity shapes EGF signaling and NLRP3-associated neuroinflammation. This article presents a causal assay framework that separates SHP2-specific effects from Shp1 activity and model-dependent biology.
-
Berberine, RXRα/PPARγ, and SASP in Atherosclerosis
2026-09-03
The reference study identifies an RXRα/PPARγ/NEDD4 mechanism through which berberine suppresses SASP-related inflammation in macrophage-derived foam cells and ApoE-deficient mice. Its combination of transcriptomic profiling, molecular readouts, and macrophage-specific RXRα knockdown provides a useful framework for testing how nuclear-receptor signaling regulates inflammatory aging in plaques.
-
ALDH2 Inhibition Targets APC-Deficient Colorectal Cancer
2026-09-02
The reference study identifies ALDH2 inhibition as a synthetic-lethal strategy for APC-deficient colorectal cancer and connects this vulnerability to persistent ROS accumulation and ASK1/JNK-dependent apoptosis. Its genotype-guided design offers a useful framework for evaluating Disulfiram in colorectal cancer models while also highlighting the need to separate ALDH2 effects from the compound’s broader pharmacology.